Nurse Practitioner, Family · Henderson, NV
NPI
1922296169
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1228 Sonatina Dr
Henderson, NV, 89052
Phone (702) 860-4458
Medicare paid, 2023
$18K
902 services
Medicare patients, 2023
182
Average age 69
Drug cost, 2024
$296K
1,936 prescriptions
Company payments, 2025
$625
From 7 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Eduardo P Monroy was code 99213 (office e&m - established), 322 times for 163 patients. In total Eduardo P Monroy billed 902 services in 29 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 322 | 163 | $36.00 | $12K |
| 81002 Clinical Chemistry | Office | 224 | 135 | $3.38 | $757 |
| 82962 Clinical Chemistry | Office | 182 | 107 | $3.17 | $578 |
| 93000 Electrocardiogram | Office | 48 | 47 | $4.56 | $219 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 23 | 23 | $101.66 | $2,338 |
By year: 2022 $13K for 612 services; 2023 $18K for 902 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 224 | 135 | $3.38 | $757 |
| 82962 Clinical Chemistry | 182 | 107 | $3.17 | $578 |
Medicare prescription drug claims, 2024
In 2024, the drug Eduardo P Monroy prescribed most often to Medicare patients was Atorvastatin Calcium, with 161 prescriptions and refills. In total Eduardo P Monroy wrote 1,936 Medicare prescriptions that cost $296K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 161 | 278 | 61 | $662 |
| Metformin Hcl Generic | 110 | 211 | 36 | $631 |
| Gabapentin Generic | 75 | 119 | 27 | $1,198 |
| Amlodipine Besylate Generic | 65 | 131 | 26 | $194 |
| Losartan Potassium Generic | 61 | 111 | 17 | $284 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 48 | 55 | 12 | $1,155 |
| Omeprazole Generic | 47 | 77 | 20 | $649 |
| Lisinopril Generic | 45 | 77 | 16 | $138 |
| Glipizide Generic | 38 | 59 | 12 | $206 |
| Levothyroxine Sodium Generic | 34 | 56 | 13 | $203 |
| Fluticasone Propionate Generic | 34 | 37 | 14 | $244 |
| Farxiga Dapagliflozin Propanediol | 33 | 60 | 15 | $30K |
| Jardiance Empagliflozin | 33 | 53 | Under 11 | $29K |
| Chlorzoxazone Generic | 31 | 31 | 26 | $29K |
| Hydrochlorothiazide Generic | 29 | 63 | Under 11 | $167 |
Brand drugs: 311 claims; generic drugs: 1,603 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eduardo P Monroy $625 ($625 in general payments such as food, travel and fees) from 7 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $184.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.